Crossvault Capital Management LLC lowered its stake in UnitedHealth Group Inc. (NYSE:UNH) by 1.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 39,870 shares of the healthcare conglomerate’s stock after selling 625 shares during the period. UnitedHealth Group comprises 4.0% of Crossvault Capital Management LLC’s investment portfolio, making the stock its 5th largest position. Crossvault Capital Management LLC’s holdings in UnitedHealth Group were worth $5,630,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the company. Dodge & Cox raised its stake in UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock valued at $1,957,113,000 after buying an additional 1,324,136 shares during the period. BlackRock Fund Advisors raised its stake in UnitedHealth Group by 1.0% in the first quarter. BlackRock Fund Advisors now owns 13,712,983 shares of the healthcare conglomerate’s stock valued at $1,767,604,000 after buying an additional 135,025 shares during the period. BlackRock Group LTD raised its stake in UnitedHealth Group by 0.7% in the first quarter. BlackRock Group LTD now owns 9,889,989 shares of the healthcare conglomerate’s stock valued at $1,274,820,000 after buying an additional 72,100 shares during the period. Geode Capital Management LLC raised its stake in UnitedHealth Group by 1.8% in the first quarter. Geode Capital Management LLC now owns 7,876,841 shares of the healthcare conglomerate’s stock valued at $1,013,308,000 after buying an additional 142,423 shares during the period. Finally, Nordea Investment Management AB raised its stake in UnitedHealth Group by 2.9% in the second quarter. Nordea Investment Management AB now owns 6,614,509 shares of the healthcare conglomerate’s stock valued at $933,969,000 after buying an additional 186,653 shares during the period. Institutional investors own 85.78% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.41% during midday trading on Wednesday, hitting $137.60. 4,625,613 shares of the stock traded hands. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $144.48. The stock has a market cap of $131.05 billion, a price-to-earnings ratio of 21.53 and a beta of 0.57. The firm has a 50-day moving average price of $138.11 and a 200 day moving average price of $136.27.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.89 by $0.07. The business had revenue of $46.50 billion for the quarter, compared to analyst estimates of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. Analysts anticipate that UnitedHealth Group Inc. will post $7.90 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were issued a dividend of $0.625 per share. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.82%. UnitedHealth Group’s payout ratio is 39.12%.
A number of equities research analysts have recently issued reports on UNH shares. Wedbush restated an “outperform” rating and issued a $165.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 19th. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target for the company in a research report on Friday, July 22nd. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 21st. Citigroup Inc. upped their price target on UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research report on Wednesday, July 20th. Finally, Credit Suisse Group AG restated a “buy” rating and issued a $148.00 price target on shares of UnitedHealth Group in a research report on Wednesday, June 29th. One equities research analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $155.35.
In related news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.65% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.